Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : WASP -- Ignore unavailable to you. Want to Upgrade?

To: Jeffrey L. Henken who wrote (74)	9/8/1999 2:01:00 PM
From: Bill Fortune III	Read Replies (1) \| Respond to of 193

Also Jeff , Kiwi and all. As an observation in regards to the recent news, just think the introduction Seven ( 7 ) Over-the-Counter products that will be made available upon FDA approval. Just think if only a couple of these take off what it will do for the company and the stock price. Then, and what if, they should all happen to be successful I don't even dare to think what will happen to the stock price. “Wasatch is a development-stage company engaged in research in the field of dermatology. It has developed a technology that treats acne, eczema and other common skin disorders without the undesirable side effects often associated with prescription drugs. Having successfully treated hundreds of patients in two prototype medical skin care clinics for over five years, the Company is positioned to expand its clinic operation and to introduce seven over-the-counter products subject to FDA approval. “ Wishing everyone the best, Bill Fortune III